DJIA 18,037.97 -42.17 -0.23%
NASDAQ 5,060.25 -31.84 -0.63%
S&P 500 2,108.92 -8.77 -0.41%
market minute promo

Novo Nordisk (NYSE: NVO)

56.78 0.13 (0.23%)

REAL-TIME: Last trade at

Extended Hours: $56.78 $0.00 (0.00%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

NVO $56.78 0.23%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $57.67
Previous Close $56.65
Daily Range $56.66 - $57.68
52-Week Range $41.72 - $57.68
Market Cap $150.5B
P/E Ratio 0.00
Dividend (Yield) $0.73 (0.9%)
Ex-Dividend Date
Dividend Pay Date
03/19/15
03/31/15
Volume 2,310,598
Average Daily Volume 2,032,074
Current FY EPS $1.78

Sector

Healthcare

Industry

Drug Makers

Novo Nordisk (NVO) Description

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals. Website: http://www.novonordisk.com/

News & Commentary Rss Feed

MannKind Corporation: Past, Present, and Future

Let's learn about the history and future prospects of MannKind as it launches its first drug, Afrezza.

Today's Top Performers In Drugs

Arena: Belviq Scripts Pop, Recover From Previous Dip

European ADRs Trading Higher as Miners Gain

Orexigen - Contrave Sales Outpace Competition, But Are Still Not Enough

What Novo Nordisk's Entry Into The Obesity Space Means To The Sector

3 Large-Cap Pharmaceutical Companies to Invest in Right Now

Novo Nordisk A/S (NVO) Moving On Heavy Volume In The Pre-Market Hours

Pre-Market Most Active for Apr 22, 2015 : NOK, ALU, NVO, KO, PKT, ASML, CHA, STM, YHOO, BRCM, FB, A

Pre-Market Most Active for Apr 22, 2015 : NOK, ALU, NVO, KO, PKT, ASML, CHA, STM, YHOO, BRCM, FB, ANGI

Novo Nordisk Will Repurchase Shares

See More NVO News...

NVO's Top Competitors

NVO $56.78 (0.23%)
Current stock: NVO
JNJ $100.58 (-0.49%)
Current stock: JNJ
PFE $34.59 (-1.93%)
Current stock: PFE
RHHBY $36.20 (-0.10%)
Current stock: RHHBY